Merck (MRK) Has an Oncology-and-Animal-Health Engine Bigger Than the Keytruda-Patent-Cliff Debate
Merck (MRK) is often reduced to one question: what happens when Keytruda eventually loses exclusivity. That debate is understandable, but ...
Thursday, July 2, 2026
Tag: KeytrudaPatentCliff
-1024x683.jpg "Strait Outta Hormuz: Getting the Iran Oil Story Straight")
-1024x683.jpg "Should the 17th Amendment Be Repealed?")
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.